Developer of a precision diagnostic assay designed to predict immune responses in oncology. Cofactor Genomics is based in Saint Louis, MO. It was valued at $41.9 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $28.7 million across 2 recorded rounds; the latest was a $6.9 million early-stage round in Dec 2021.
PMV mark · valuation
$41.9M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$28.7M
Last round
Early Stage VC
Dec 2021
Cap table — not yet on record
Cofactor Genomics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cofactor Genomics with a free account
·The complete investor list: 30 names
·Watch Cofactor Genomics: the Monday email on marks, rounds and moves
Where does Cofactor Genomics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cofactor Genomics's 2 recorded funding rounds.
